WagnerJ. G.: Fallacy in Concluding There Are Zero-Order Kinetics from Blood Level and Urinary Excretion Data, J. Pharm. Sci.56: 586–594 (1967.).
2.
DominguezR., and PomereneE.: Calculation of the Rate of Absorption of Exogenous Creatinine, Proc. Soc. Exptl. Biol. Med.60: 173–181 (1945).
3.
ChulskiT., JohnsonR. H., SchlagelC. A., and WagnerJ.G.: Direct Proportionality of Urinary Excretion Rate and Serum Level of Tetracycline in Human Subjects, Nature198: 450–453 (1963).
4.
WagnerJ. G.: Design and Data Analysis of Biopharmaceutical Studies in Man, Can. J. Pharm. Sci.1: 55–68 (1967b).
5.
SmithH. W.: “Principles of Renal Physiology,”Oxford University Press, New York, 1956.
6.
SmithH. W.: “The Kidney, Structure and Function in Health and Disease,”Oxford University Press, New York, 1951. (a) p. 176, 180, 181; (b) p. 145.
7.
NelsonE.: Kinetics of Drug Absorption, Distribution, Metabolism and Excretion, J. Pharm. Sci.50: 181–192 (1961).
8.
KoizumiT., AritaT., and KokemiK.: Absorption and Excretion of Drugs. XXI. Some Pharmokinetic Aspects of Absorption and Excretion of Sulfonamide. (3) Excretion from the Kidney, Chem. Pharm. Bull. (Tokyo)12: 428 (1964).
9.
ConnR. G., SaboA. J., LenderD., and HoJ. Y. L.: Inconstancy of Renal Clearance Values with Changing Plasma Concentrations, Nature203: 143 (1964).
10.
Krüger-ThiemerE., and BüngerP.: Experimental Studies and Clinical Experience—the Assessment of Risk,” Excerpta Medica International Congress Series No. 97. Proceedings of the European Society for the Study of Drug Toxicity, meeting in Stockholm, Sweden, June 1965, Vol. VI, p. 185–207, Excepta Medica Foundation.
11.
WagnerJ. G.: Equation for Excretion Rate and Renal Clearances of Exogenous Substances Not Actively Reabsorbed, J. Clin. Pharmacol.7: 89–91 (1967c).
